Wikidata

(Q61915196)

English

Rituximab, Combination Chemotherapy, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed Follicular Non-Hodgkin Lymphoma

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

title
Short Chemo Radiotherapy in Follicular Lymphoma Trial of 90Y Ibritumomab Tiuxetan (ZevalinTM) as Therapy for First and Second Relapse in Follicular Lymphoma (English)
0 references
country
United Kingdom
0 references
start time
April 2008
0 references
end time
March 2010
0 references
number of participants
100
0 references
research intervention
(RS)-cyclophosphamide
0 references
rituximab
0 references
Caelyx
0 references
doxorubicin
0 references
vincristine
0 references
prednisolone
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61915196&oldid=2166521809"